| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.7M | — | -14.7% |
| Cost of Revenue | $7.6M | — | -28.5% |
| Gross Profit | $5.1M | — | +20.1% |
| R&D Expense | $629K | — | -25.3% |
| SG&A Expense | $4.2M | — | +0.0% |
| Operating Income | -$1.0M | — | +61.6% |
| Pre-tax Income | -$1.2M | — | +55.2% |
| Income Tax | -$169K | — | +68.7% |
| Net Income | -$1.0M | — | +51.8% |
| EPS (Basic) | -$0.02 | — | +60.0% |
| EPS (Diluted) | -$0.02 | — | +60.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.1M | -28.3% | — |
| Accounts Receivable | $4.1M | -23.3% | -26.9% |
| Inventory | $23.9M | -8.0% | -1.8% |
| Current Assets | $32.9M | -17.4% | -6.2% |
| Total Assets | $44.3M | -13.9% | -4.5% |
| Current Liabilities | $16.6M | -25.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.4M | — | +58.8% |
| Capital Expenditures | $262K | — | — |
| Investing Cash Flow | -$252K | — | +91.6% |
| Financing Cash Flow | -$12K | — | +99.6% |
| Free Cash Flow | -$1.6M | — | — |
| -15.1% |
| Total Liabilities | $21.6M | -22.0% | -18.3% |
| Stockholders' Equity | $22.7M | -4.4% | +13.9% |